127 related articles for article (PubMed ID: 18769118)
41. Extranodal NK/T-cell lymphoma: diagnosis and treatment cues.
Suzuki R; Takeuchi K; Ohshima K; Nakamura S
Hematol Oncol; 2008 Jun; 26(2):66-72. PubMed ID: 18283711
[TBL] [Abstract][Full Text] [Related]
42. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
[TBL] [Abstract][Full Text] [Related]
43. The interaction between Vav1 and EBNA1 promotes survival of Burkitt's lymphoma cells by down-regulating the expression of Bim.
Wang R; Wang J; Zhang N; Wan Y; Liu Y; Zhang L; Pan S; Zhang C; Zhang H; Cao Y
Biochem Biophys Res Commun; 2019 Apr; 511(4):787-793. PubMed ID: 30833082
[TBL] [Abstract][Full Text] [Related]
44. Sequence Variation Analysis of Epstein-Barr Virus Nuclear Antigen 1 Gene in the Virus Associated Lymphomas of Northern China.
Sun L; Zhao Z; Liu S; Liu X; Sun Z; Luo B
PLoS One; 2015; 10(10):e0140529. PubMed ID: 26460969
[TBL] [Abstract][Full Text] [Related]
45. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
[TBL] [Abstract][Full Text] [Related]
46. NK/T-cell lymphoma associated with Epstein-Barr virus in a patient infected with human immunodeficiency virus: an autopsy case.
Oh SC; Choi CW; Kim BS; Shin SW; Kim YH; Lee JS; Kim MJ; Jung WY; Kim HK; Yeom BW; Kim IS; Kim JS
Int J Hematol; 2004 Jun; 79(5):480-3. PubMed ID: 15239400
[TBL] [Abstract][Full Text] [Related]
47. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.
Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J
Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425
[TBL] [Abstract][Full Text] [Related]
48. CD21-independent Epstein-Barr virus entry into NK cells.
Lee JH; Choi J; Ahn YO; Kim TM; Heo DS
Cell Immunol; 2018 May; 327():21-25. PubMed ID: 29499908
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathological features of Epstein-Barr virus-associated nasal T/NK cell lymphomas in southern Japan.
Seki D; Ueno K; Kurono Y; Eizuru Y
Auris Nasus Larynx; 2001 Jan; 28(1):61-70. PubMed ID: 11137365
[TBL] [Abstract][Full Text] [Related]
50. The Hsp70 inhibitor 2-phenylethynesulfonamide inhibits replication and carcinogenicity of Epstein-Barr virus by inhibiting the molecular chaperone function of Hsp70.
Wang H; Bu L; Wang C; Zhang Y; Zhou H; Zhang X; Guo W; Long C; Guo D; Sun X
Cell Death Dis; 2018 Jun; 9(7):734. PubMed ID: 29959331
[TBL] [Abstract][Full Text] [Related]
51. Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus.
Kagami Y; Nakamura S; Suzuki R; Iida S; Yatabe Y; Okada Y; Kobayashi T; Tsurumi T; Seto M; Ogura M; Taguchi O; Morishima Y
Br J Haematol; 1998 Dec; 103(3):669-77. PubMed ID: 9858215
[TBL] [Abstract][Full Text] [Related]
52. Epstein-Barr virus and human herpesvirus 8 coinfection and concomitant extranodal nasal-type NK/T cell lymphoma and Castleman disease: case report.
Larroche C; Agbalika F; Poirel H; Martin A; Gautheret-Dejean A; Raphaël M; Lortholary O
Clin Infect Dis; 2003 May; 36(9):e107-10. PubMed ID: 12715327
[TBL] [Abstract][Full Text] [Related]
53. Epstein-Barr virus-associated extranodal NK/T-cell lymphoma, nasal type of the hypopharynx, in a renal allograft recipient: case report and review of literature.
Stadlmann S; Fend F; Moser P; Obrist P; Greil R; Dirnhofer S
Hum Pathol; 2001 Nov; 32(11):1264-8. PubMed ID: 11727268
[TBL] [Abstract][Full Text] [Related]
54. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.
Xu WS; Chan AC; Lee JM; Liang RH; Ho FC; Srivastava G
J Med Virol; 1998 Dec; 56(4):342-50. PubMed ID: 9829640
[TBL] [Abstract][Full Text] [Related]
55. Development of Extranodal NK/T-cell Lymphoma Nasal Type in Cerebrum Following Epstein-Barr Virus-positive Uveitis.
Imai A; Takase H; Imadome KI; Matsuda G; Ohnishi I; Yamamoto K; Kudo T; Tanaka Y; Maehara T; Miura O; Arai A
Intern Med; 2017; 56(11):1409-1414. PubMed ID: 28566607
[TBL] [Abstract][Full Text] [Related]
56. Curcumin Inhibits Proliferation of Epstein-Barr Virus-Associated Human Nasopharyngeal Carcinoma Cells by Inhibiting EBV Nuclear Antigen 1 Expression.
Liu L; Yang J; Ji W; Wang C
Biomed Res Int; 2019; 2019():8592921. PubMed ID: 31687403
[TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr virus (EBV)-induced CD30+ natural killer cell-type malignancy resembling malignant histiocytosis: malignant transformation in chronic active EBV infection associating hypogammaglobulinemia.
Tsutsumi Y; Tang X; Yamada T
Pathol Int; 1997 Jun; 47(6):384-92. PubMed ID: 9211526
[TBL] [Abstract][Full Text] [Related]
58. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
[TBL] [Abstract][Full Text] [Related]
59. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
[TBL] [Abstract][Full Text] [Related]
60. Epstein-Barr Virus-associated Lymphoproliferative Disorders in the Skin.
Goodlad JR
Surg Pathol Clin; 2017 Jun; 10(2):429-453. PubMed ID: 28477890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
